MIAMI, Fla., USA: Neocis, a supplier of robot-assisted dental implant surgery, has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new Yomi edentulous indication.
According to Neocis, the clearance allows for a new splint attachment that broadens Yomi’s application to include full-arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that more than 36 million Americans are missing all their teeth. The new Yomi edentulous splint will enable doctors to use Yomi’s technology to reach more of this population, Neocis said.
“I am delighted today to report that we have received 510(k) clearance for Yomi to assist with full arch implant surgeries. With this clearance, Yomi doctors will be able to leverage robotic technology to treat more patients and restore more smiles,” said Alon Mozes, PhD, CEO of Neocis.